What Researchers Did
Researchers conducted a randomized clinical trial in the Netherlands to assess the effectiveness of hyperbaric oxygen therapy for late local toxic effects in women who received adjuvant radiotherapy for breast cancer.
What They Found
The trial enrolled 125 women (median age 56 years) with late local toxic effects after breast irradiation between November 2019 and August 2022. The provided abstract is truncated and does not include the specific findings regarding the effectiveness of hyperbaric oxygen therapy on the primary or secondary outcomes.
What This Means for Canadian Patients
If hyperbaric oxygen therapy proves effective, it could offer a new treatment option for Canadian women experiencing late local toxic effects after breast cancer radiotherapy. Patients should discuss current treatment options and potential future therapies with their healthcare providers as more evidence becomes available.
Canadian Relevance
This study was conducted in the Netherlands and has no direct Canadian connection.
Study Limitations
The provided abstract does not detail specific study limitations.